Cardiology · Arrhythmias
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
ECG shows ≥3 distinct P-wave morphologies in one lead with an atrial rate >100 bpm and irregular PR intervals.
Strongly associated with severe COPD exacerbations, and also with hypokalemia, hypomagnesemia, and theophylline toxicity.
Produces an irregularly irregular pulse that mimics atrial fibrillation but retains discrete P waves.
First-line treatment is correcting the underlying cause (optimize COPD, replace K+ and Mg2+).
If rate control is needed use verapamil or diltiazem, and avoid beta-blockers in reactive airway disease.
Same morphology criteria with an atrial rate <100 bpm defines wandering atrial pacemaker, not MAT.
Electrical cardioversion and amiodarone are ineffective and contraindicated because the rhythm is automatic, not reentrant.
Vignette unlocked
A 68-year-old man with severe COPD on home oxygen presents with worsening dyspnea and wheezing over 3 days. He is afebrile, tachypneic, and has an oxygen saturation of 86% on room air. His pulse is irregularly irregular at 118/min. A 12-lead ECG shows an atrial rate of 115/min with at least three distinct P-wave morphologies in lead II and varying PR intervals.
Which of the following is the most appropriate initial management?
Treat the underlying COPD exacerbation with bronchodilators, oxygen, and correction of electrolyte abnormalities.
Multifocal atrial tachycardia is driven by increased atrial automaticity from hypoxemia and atrial stretch, so correcting the precipitating pulmonary and metabolic derangements is first-line. Beta-blockers are avoided in reactive airway disease, and cardioversion is ineffective for this automatic rhythm.
Full handout
High yield triage
Etiology / Epidemiology
Strongly associated with severe COPD and pulmonary exacerbations, as well as hypokalemia, hypomagnesemia, and theophylline toxicity.
Clinical Manifestations
Often asymptomatic regarding the arrhythmia itself, but presents with an irregularly irregular pulse mimicking atrial fibrillation alongside worsening dyspnea.
Diagnosis
ECG shows ≥3 distinct P-wave morphologies in the same lead with an atrial rate >100 bpm and an irregular PR interval.
Treatment
Treat the underlying cause (e.g., optimize COPD); if rate control is required, use verapamil or diltiazem, while being sure to avoid beta-blockers in reactive airway disease.
Prognosis
Resolves with correction of the underlying pulmonary or metabolic illness, but can rarely cause hemodynamic instability if sustained at high rates.
Full handout
Epidemiology & Etiology
Primarily affects elderly patients with advanced pulmonary disease, most classically during COPD exacerbations. Other triggers include acute respiratory failure, sepsis, hypokalemia, hypomagnesemia, and theophylline toxicity. It is highly board-tested due to its specific pulmonary associations and frequent occurrence in patients developing cor pulmonale.
Pertinent Anatomy
Arises from multiple ectopic pacemakers located throughout the right and left atrial myocardium. These distinct foci bypass the normal sinoatrial node pathway, leading to variable atrial depolarization vectors. This anatomical irritability is often exacerbated by right atrial dilation and hypertrophy seen in chronic lung disease.
Pathophysiology
Chronic hypoxemia, pulmonary hypertension, and right atrial stretch increase atrial wall tension. This stretch, combined with elevated sympathetic tone and metabolic derangements, triggers increased automaticity in multiple ectopic atrial foci. Each focus generates its own impulse, resulting in variable AV node conduction and an irregular ventricular response, distinct from the microreentrant circuits seen in atrial fibrillation.
Clinical Manifestations
Patients typically present with symptoms of their underlying disease, such as worsening dyspnea, hypoxemia, and wheezing from COPD. The hallmark physical exam finding is an irregularly irregular pulse that is clinically indistinguishable from atrial fibrillation. Patients may report palpitations or exhibit hemodynamic compromise or syncope if the rapid ventricular rate severely limits diastolic cardiac filling.
Diagnosis
The gold standard is a 12-lead ECG demonstrating ≥3 distinct P-wave morphologies in a single lead (classically lead II, III, or aVF). The atrial rate must be >100 bpm with an irregular PR interval and irregular R-R intervals. If the rate is <100 bpm with the exact same morphology criteria, the diagnosis is wandering atrial pacemaker. Continuous telemetry is used to monitor rate trends and rule out ischemia.
Treatment
The absolute first-line therapy is to treat the underlying cause, typically through COPD optimization (bronchodilators, oxygen, steroids) and correcting electrolyte deficits (replace K+ and Mg2+). If the patient remains tachycardic and symptomatic after underlying treatment, verapamil or diltiazem are the preferred rate-control agents. Avoid beta-blockers due to the high risk of exacerbating bronchospasm in severe COPD patients. Electrical cardioversion and antiarrhythmics like amiodarone are ineffective and contraindicated.
Prognosis
Prognosis is heavily dictated by the severity of the underlying cardiopulmonary disease rather than the arrhythmia itself. MAT typically resolves once the respiratory failure or metabolic derangement is corrected. Failure to treat the underlying cause can lead to myocardial ischemia, hemodynamic collapse, or progression to sustained atrial fibrillation.
Differential Diagnosis
1. Atrial fibrillation: Irregularly irregular rhythm but completely lacks distinct P waves.
2. Wandering atrial pacemaker: Demonstrates ≥3 distinct P-wave morphologies but the atrial rate is strictly <100 bpm.
3. Atrial flutter with variable block: ECG shows classic sawtooth flutter waves rather than distinct isoelectric baselines and P waves.
4. Sinus tachycardia with frequent premature atrial contractions (PACs): Underlying regular sinus rhythm interrupted by early beats, unlike the completely chaotic baseline of MAT.